Henrik Imberg (H Imberg)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Clinical Practice

Cardiovascular Disease

Silver Nanoparticles

Top Venues

Journal of diabetes science and technology

Obesity science & practice

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, Johan Jendle, Bengt-Olov Tengmark, Anna Folino, Ekström Marie, Marcus Lind
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes. Journal of diabetes science and technology (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, Johan Jendle, Bengt-Olov Tengmark, Anna Folino, Ekström Marie, Marcus Lind
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes. Journal of diabetes science and technology (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia (2024)
Catherine Anne Cluver, L Bergman, J Bergkvist, Henrik Imberg, Lut Geerts, D R Hall, Ben-Willem J Mol, S Tong, S P Walker
Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre-eclampsia. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2023)
S S Ahmadi, K Filipsson, H Dimenäs, S S Isaksson, Henrik Imberg, S Sjöberg, Bo Ahrén, S Dahlqvist, T Gustafsson, J Tuomilehto, I B Hirsch, Marcus Lind
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5). Obesity science & practice 5 (2) (2019)
Lenka Novakova, Markus Axelsson, Clas Malmeström, Henrik Imberg, Olle Elias, Henrik Zetterberg, Olle Nerman, Jan Lycke
Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers. PloS one 13 (4) (2018)